Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer

NCT00789633 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

353

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Masitinib
DRUG: Placebo
DRUG: Gemcitabine

Sponsor

AB Science